RESUMEN

BACKGROUND AND AIM: Irisin, a novel myocyte-secreted hormone, was proposed to mediate some of the beneficial effects of exercise such as browning of adipocytes, thermogenesis, and metabolic homeostasis. Recently, several animals' models' studies have been performed to investigate the therapeutic impact of irisin in several disorders. Several interventional trials used different doses. However, optimum dose was not determined. This systematic review aims to identify the optimal dose of interventional irisin in mice and rat animal models. MATERIALS AND METHODS: Online databases PubMed, Google Scholar, and Springer were systematically searched from 2012 to 2019. The words searched were irisin, irisin and animal model, physical activity, and irisin and irisin dosage. Non-irisin doses, in vitro studies, and factors influencing irisin levels were excluded. RESULTS: Eleven of the total 391 qualifying studies were included. A daily injection of 500 µg/kg irisin may be the optimum dose of effect in mice and rats. CONCLUSION: More studies are required to determine the optimum dose of irisin to be used as a therapeutic intervention based on animal model.